Pulmonx Corporation (LUNG) Stock
Healthcare · Medical Devices · Member of Other US Stocks
Pulmonx Corporation (LUNG) closed at USD 1.78 on 2026-10-14, a change of -10.1 % over the past year, with a market capitalization of USD 78.14M.
Pulmonx Corporation recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 1.78 |
| 2026-10-13 | 1.76 |
| 2026-10-12 | 1.80 |
| 2026-10-09 | 1.84 |
| 2026-10-08 | 1.81 |
| 2026-10-07 | 1.84 |
| 2026-10-06 | 1.78 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Pulmonx Corporation key figures
- Previous close
- USD 1.78 (2026-10-14)
- 1-year change
- -10.1 %
- Market cap
- USD 78.14M
- Enterprise value
- USD 79.82M
- P/E ratio (trailing)
- -1.61
- P/E ratio (forward)
- -1.96
- EPS (trailing)
- -1.15
- EPS (forward)
- -0.94
- PEG ratio
- n/a
- Price to book
- 2.03
- Revenue growth
- -4.6 %
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 2.70
- Employees
- 296
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Pulmonx Corporation
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Pulmonx Corporation and compare it with other stocks.
Analyze LUNGAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Pulmonx Corporation shares.